These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 19143484)

  • 1. Prevalence of a 32 bp deletion in the gene for human immunodeficiency virus 1 co-receptor CCR5 in Slovak population.
    Takácová M; Nogová P; Hábeková M; Staneková D
    Acta Virol; 2008; 52(4):261-4. PubMed ID: 19143484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of the HIV resistance CCR5-Delta32 allele among Egyptians and Syrians.
    Salem AH; Batzer MA
    Mutat Res; 2007 Mar; 616(1-2):175-80. PubMed ID: 17166523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency of CCR5-Delta32 deletion in human immunodeficiency virus type 1 (HIV-1) in healthy blood donors, HIV-1-exposed seronegative and HIV-1-seropositive individuals of southern Brazilian population.
    Reiche EM; Ehara Watanabe MA; Bonametti AM; Morimoto HK; Akira Morimoto A; Wiechmann SL; Matsuo T; Carvalho De Oliveira J; Vissoci Reiche F
    Int J Mol Med; 2008 Nov; 22(5):669-75. PubMed ID: 18949389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of the CCR5Delta32 mutation in Brazilian populations and cell susceptibility to HIV-1 infection.
    Grimaldi R; Shindo N; Acosta AX; Dourado I; Brites C; de Melo Carvalho O; Brito I; Bou-Habib DC; Galvão-Castro B
    Hum Genet; 2002 Jul; 111(1):102-4. PubMed ID: 12136242
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced prevalence of the CCR5 delta32 heterozygous genotype in human immunodeficiency virus-infected individuals with AIDS dementia complex.
    van Rij RP; Portegies P; Hallaby T; Lange JM; Visser J; de Roda Husman AM; van 't Wout AB; Schuitemaker H
    J Infect Dis; 1999 Sep; 180(3):854-7. PubMed ID: 10438379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The HIV type 1 coreceptor CCR5 and its role in viral transmission and disease progression.
    Paxton WA; Kang S; Koup RA
    AIDS Res Hum Retroviruses; 1998 Apr; 14 Suppl 1():S89-92. PubMed ID: 9581891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distribution of the mutated delta 32 allele of the CCR5 gene in a Sicilian population.
    Sidoti A; D'Angelo R; Rinaldi C; De Luca G; Pino F; Salpietro C; Giunta DE; Saltalamacchia F; Amato A
    Int J Immunogenet; 2005 Jun; 32(3):193-8. PubMed ID: 15932625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of the CCR5-Delta32 HIV resistance allele and new mutations of the CCR5 gene in different Tunisian populations.
    Jlizi A; Edouard J; Fadhlaoui-Zid K; Frigi S; Debré P; Slim A; Theodorou I; El Gaaied AB; Carpentier W
    Hum Immunol; 2007 Dec; 68(12):993-1000. PubMed ID: 18191728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of mutant CCR5 allele in Slovenian HIV-1-infected and non-infected individuals.
    Poljak M; Tomazic J; Seme K; Maticic M; Vidmar L
    Acta Virol; 1998 Feb; 42(1):23-6. PubMed ID: 9645239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution of HIV/AIDS protective SDF1, CCR5 and CCR2 gene variants within Cretan population.
    Apostolakis S; Baritaki S; Krambovitis E; Spandidos DA
    J Clin Virol; 2005 Dec; 34(4):310-4. PubMed ID: 16286055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of 32 alelle of the CCR5 gene in the population of Poland.
    Jagodzinski PP; Lecybył R; Ignacak M; Juszczyk J; Trzeciak WH
    J Hum Genet; 2000; 45(5):271-4. PubMed ID: 11043507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of CCR5-Delta32, CCR5m303A, CCR2-64I and SDF1-3'A in HIV-1 infected and uninfected high-risk Uighurs in Xinjiang, China.
    Tan XH; Zhang JY; Di CH; Hu AR; Yang L; Qu S; Zhao RL; Yang PR; Guo SX
    Infect Genet Evol; 2010 Mar; 10(2):268-72. PubMed ID: 19958843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of CCR5-delta32, CCR2-64I and SDF-1-3'A polymorphic alleles on human immunodeficiency virus 1 (HIV-1) infection in the Polish population].
    Wasik TJ; Smoleń J; Kruszyński P; Bratosiewicz-Wasik J; Beniowski M
    Wiad Lek; 2005; 58(9-10):500-7. PubMed ID: 16529059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the 32 bp deletion in the CCR5 chemokine receptor gene in people from Moscow, infected with HIV-1].
    Shadrina MI; Kapylov VM; Miloserdova OV; Slominskiĭ PA; Limborskaia SA
    Genetika; 2000 May; 36(5):718-20. PubMed ID: 10867893
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians.
    Kaur G; Singh P; Rapthap CC; Kumar N; Vajpayee M; Sharma SK; Wanchu A; Mehra NK
    Hum Immunol; 2007 May; 68(5):454-61. PubMed ID: 17462514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved virological response to highly active antiretroviral therapy in HIV-1-infected patients carrying the CCR5 Delta32 deletion.
    Laurichesse JJ; Persoz A; Theodorou I; Rouzioux C; Delfraissy JF; Meyer L
    HIV Med; 2007 May; 8(4):213-9. PubMed ID: 17461848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 32-nucleotide deletion, associated with defence against hiv/aids, is a predominant mutation of CCR5 gene in the population of Georgia.
    Kamkamidze G; Capoulade-Metay C; Butsashvili M; Dudoit Y; Chubinishvili O; Debre P; Theodorou L
    Georgian Med News; 2005 Jan; (118):74-9. PubMed ID: 15821335
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CC chemokine receptor 5 polymorphism in rheumatoid arthritis.
    Garred P; Madsen HO; Petersen J; Marquart H; Hansen TM; Freiesleben Sørensen S; Volck B; Svejgaard A; Andersen V
    J Rheumatol; 1998 Aug; 25(8):1462-5. PubMed ID: 9712084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced HIV-1 infectability of CD4+ lymphocytes from exposed-uninfected individuals: association with low expression of CCR5 and high production of beta-chemokines.
    Paxton WA; Liu R; Kang S; Wu L; Gingeras TR; Landau NR; Mackay CR; Koup RA
    Virology; 1998 Apr; 244(1):66-73. PubMed ID: 9581779
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic variations in CC chemokine receptors and hypertension.
    Zhang M; Ardlie K; Wacholder S; Welch R; Chanock S; O'Brien TR
    Am J Hypertens; 2006 Jan; 19(1):67-72. PubMed ID: 16461193
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.